LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 67.41 | 84.90 | 311 | 8766 | 0.0355 | 0.2142 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.11 | 84.90 | 43 | 8988 | 0.0048 | -0.0962 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.11 | 84.90 | 1028 | 8988 | 0.1144 | 0.4489 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.11 | 84.90 | 1 | 8988 | 0.0001 | -0.4833 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.11 | 84.90 | 259 | 8988 | 0.0288 | 0.1804 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 70.81 | 84.90 | 42 | 9132 | 0.0046 | -0.0990 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 70.81 | 84.90 | 977 | 9132 | 0.1070 | 0.4362 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 70.81 | 84.90 | 1 | 9132 | 0.0001 | -0.4822 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 70.81 | 84.90 | 210 | 9132 | 0.0230 | 0.1436 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 72.52 | 84.90 | 36 | 9214 | 0.0039 | -0.1192 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 72.52 | 84.90 | 957 | 9214 | 0.1039 | 0.4308 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 72.52 | 84.90 | 1 | 9214 | 0.0001 | -0.4815 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 72.52 | 84.90 | 164 | 9214 | 0.0178 | 0.1023 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.22 | 84.90 | 40 | 9343 | 0.0043 | -0.1050 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.22 | 84.90 | 1110 | 9343 | 0.1188 | 0.4609 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.22 | 84.90 | 1 | 9343 | 0.0001 | -0.4805 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 74.22 | 84.90 | 133 | 9343 | 0.0142 | 0.0684 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.93 | 84.90 | 49 | 8970 | 0.0055 | -0.0785 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.93 | 84.90 | 1087 | 8970 | 0.1212 | 0.4612 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.93 | 84.90 | 1 | 8970 | 0.0001 | -0.4835 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 75.93 | 84.90 | 104 | 8970 | 0.0116 | 0.0306 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 77.64 | 84.90 | 45 | 9245 | 0.0049 | -0.0895 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 77.64 | 84.90 | 1110 | 9245 | 0.1201 | 0.4621 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 77.64 | 84.90 | 1 | 9245 | 0.0001 | -0.4813 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 77.64 | 84.90 | 77 | 9245 | 0.0083 | -0.0143 | MN20160318_Q02 | K04 |